Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus.
Authorization of the vaccine adds nearly 17 million more Americans to the pool of those eligible to be immunized against COVID-19.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
Pfizer/BioNTech’s coronavirus vaccine is 95% effective for preventing symptomatic illness.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Stop me if you’ve heard this one before.
With the mutation, people seem to make slightly more insulin and have slightly lower blood glucose levels than normal throughout their lives.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.